Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weinberg, C. R.
Right arrow Articles by Pfeifer, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weinberg, C. R.
Right arrow Articles by Pfeifer, M. A.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 35, Issue 8 873-880, Copyright © 1986 by American Diabetes Association


ARTICLES

Development of a predictive model for symptomatic neuropathy in diabetes

CR Weinberg and MA Pfeifer

In evaluating therapeutic interventions aimed at preventing diabetic neuropathy, choosing a suitable measure of neural function is difficult, partly because the relation between most available objective measures and the development of symptomatic neuropathy (SN) is unclear. Using data from 67 diabetic patients, we developed a linear logistic regression model to assess the relationship between SN and a set of neural measures, including dark-adapted pupil size; pupillary latency; heart rate; a measure of respiratory sinus arrhythmia (R); the Valsalva ratio; and conduction velocities for the peroneal, median motor, and median sensory nerves. Models allowed for possible effects related to age, sex, duration and type of diabetes, glycosylated hemoglobin, and adiposity. Thirty-two of the patients reported SN (autonomic and/or sensorimotor). The best-fitting model for predicting the presence of any SN included only heart rate, duration of disease, and R. Exclusion of duration (P less than .01), or heart rate (P less than .05), or R (P less than .001) significantly impaired the fit of the model. To evaluate the temporally predictive power of the model, nine of the asymptomatic patients were reinterviewed 2 yr later by the same interviewer, who was unaware of the results of the modeling. Four of five to whom the model had assigned high probability of symptoms had indeed developed SN during the follow-up period, whereas none of the four assigned low probability had developed SN (P less than .05). Thus it seems that a measure of respiratory sinus arrhythmia provides an index of neural function strongly related to SN, and our follow-up data suggest that diminished R can be used to predict the development of SN in diabetes.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Diabetes CareHome page
A. I. Vinik, R. E. Maser, B. D. Mitchell, and R. Freeman
Diabetic Autonomic Neuropathy
Diabetes Care, May 1, 2003; 26(5): 1553 - 1579.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1986 by the American Diabetes Association.